SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lucilla Nobbio, Davide Visigalli, Elena Mannino, Fulvia Fiorese, Matthias U. Kassack, Laura Sturla, Valeria Prada, Antonio De Flora, Elena Zocchi, Santina Bruzzone, Angelo Schenone, The Diadenosine Homodinucleotide P18 Improves In Vitro Myelination in Experimental Charcot-Marie-Tooth Type 1A, Journal of Cellular Biochemistry, 2014, 115, 1
  2. 2
    Gael B. Morrow, Robert A. Nicholas, Charles Kennedy, UTP is not a biased agonist at human P2Y11 receptors, Purinergic Signalling, 2014, 10, 4, 581

    CrossRef

  3. 3
    Zoubir Djerada, Hélène Peyret, Sylvain Dukic, Hervé Millart, Extracellular NAADP affords cardioprotection against ischemia and reperfusion injury and involves the P2Y11-like receptor, Biochemical and Biophysical Research Communications, 2013, 434, 3, 428

    CrossRef

  4. 4
    Charles Kennedy, Krongkarn Chootip, Callum Mitchell, Nawazish-i-Husain Syed, Asrin Tengah, P2X and P2Y nucleotide receptors as targets in cardiovascular disease, Future Medicinal Chemistry, 2013, 5, 4, 431

    CrossRef

  5. You have free access to this content5
    Kenneth A. Jacobson, M.P. Suresh Jayasekara, Stefano Costanzi, Molecular structure of P2Y receptors: mutagenesis, modeling, and chemical probes, Wiley Interdisciplinary Reviews: Membrane Transport and Signaling, 2012, 1, 6
  6. 6
    Evgeny Zemskov, Rudolf Lucas, Alexander D. Verin, Nagavedi S. Umapathy, P2Y receptors as regulators of lung endothelial barrier integrity, Journal of Cardiovascular Disease Research, 2011, 2, 1, 14

    CrossRef

  7. You have free access to this content7
    Robin Haw, Henning Hermjakob, Peter D'Eustachio, Lincoln Stein, Reactome pathway analysis to enrich biological discovery in proteomics data sets, PROTEOMICS, 2011, 11, 18
  8. 8
    Ai-Dong Qi, Dayle Houston-Cohen, Isabella Naruszewicz, T Kendall Harden, Robert A Nicholas, Ser352 and Ser354 in the carboxyl terminus of the human P2Y1 receptor are required for agonist-promoted phosphorylation and internalization in MDCK cells, British Journal of Pharmacology, 2011, 162, 6
  9. 9
    Ivar von Kügelgen, T. Kendall Harden, Pharmacology of Purine and Pyrimidine Receptors, 2011,

    CrossRef

  10. 10
    T. K. Harden, J. I. Sesma, I. P. Fricks, E. R. Lazarowski, Signalling and pharmacological properties of the P2Y14 receptor, Acta Physiologica, 2010, 199, 2
  11. 11
    Invited Lectures, Purinergic Signalling, 2006, 2, 1, 1

    CrossRef

  12. 12
    Laurie Erb, Zhongji Liao, Cheikh I. Seye, Gary A. Weisman, P2 receptors: intracellular signaling, Pflügers Archiv - European Journal of Physiology, 2006, 452, 5, 552

    CrossRef

  13. 13
    Masami Son, Yasushi Ito, Shinji Sato, Takayuki Ishikawa, Masashi Kondo, Shinsuke Nakayama, Kaoru Shimokata, Hiroaki Kume, Apical and Basolateral ATP-Induced Anion Secretion in Polarized Human Airway Epithelia, American Journal of Respiratory Cell and Molecular Biology, 2004, 30, 3, 411

    CrossRef

  14. 14
    Liaman K Mamedova, Bhalchandra V Joshi, Zhan-Guo Gao, Ivar von Kügelgen, Kenneth A Jacobson, Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors, Biochemical Pharmacology, 2004, 67, 9, 1763

    CrossRef

  15. 15
    Ai-Dong Qi, T. Kendall Harden, Robert A. Nicholas, GPR80/99, proposed to be the P2Y15 receptor activated by adenosine and AMP, is not a P2Y receptor, Purinergic Signalling, 2004, 1, 1, 67

    CrossRef

  16. 16
    K. Van Crombruggen, R. A. Lefebvre, Nitrergic–purinergic interactions in rat distal colon motility, Neurogastroenterology & Motility, 2004, 16, 1
  17. 17
    Eduardo R Lazarowski, 2003,

    CrossRef